Literature DB >> 28687234

Myeloid-derived suppressor cells modulate B-cell responses.

Felipe J N Lelis1, Jennifer Jaufmann2, Anurag Singh3, Katja Fromm4, Annkathrin Chiara Teschner3, Simone Pöschel5, Iris Schäfer3, Sandra Beer-Hammer2, Nikolaus Rieber6, Dominik Hartl7.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are key regulators of adaptive immunity by suppressing T-cell functions. However, their potential action on or interaction with B cells remained poorly understood. Here we demonstrate that human polymorphonuclear MDSCs differentially modulate B-cell function by suppressing B-cell proliferation and antibody production. We further demonstrate that this MDSC-mediated effect is cell contact dependent and involves established mediators such as arginase-1, nitric oxide (NO), reactive oxygen species (ROS) as well as B-cell death. Collectively, our studies provide novel evidence that human MDSCs modulate B cells, which could have future implications for immunotherapy approaches.
Copyright © 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cells; MDSCs; Myeloid-derived suppressor cells

Mesh:

Substances:

Year:  2017        PMID: 28687234     DOI: 10.1016/j.imlet.2017.07.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  23 in total

1.  Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Athanasios Mavropoulos; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Biomed Rep       Date:  2017-09-11

Review 2.  Recent advances on the crosstalk between neutrophils and B or T lymphocytes.

Authors:  Sara Costa; Dalila Bevilacqua; Marco A Cassatella; Patrizia Scapini
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

3.  The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.

Authors:  Defne Bayik; Juyeun Lee; Justin D Lathia
Journal:  Exp Suppl       Date:  2022

4.  Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity.

Authors:  Mingqian Zhou; Paul Dascani; Chuanlin Ding; Justin T Kos; David Tieri; Xiaoying Lin; Dawn Caster; David Powell; Chengping Wen; Corey T Watson; Jun Yan
Journal:  J Immunol       Date:  2021-09-01       Impact factor: 5.426

Review 5.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

6.  Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.

Authors:  Simon H Murch
Journal:  Med Hypotheses       Date:  2020-08-07       Impact factor: 1.538

Review 7.  Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression.

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

Review 8.  Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.

Authors:  Weitao Zhang; Jiawei Li; Guisheng Qi; Guowei Tu; Cheng Yang; Ming Xu
Journal:  J Transl Med       Date:  2018-01-29       Impact factor: 5.531

Review 9.  Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses.

Authors:  Bilgenaz Özkan; Heejin Lim; Sung-Gyoo Park
Journal:  Int J Mol Sci       Date:  2018-05-15       Impact factor: 5.923

10.  Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity.

Authors:  Benjamin Knier; Michael Hiltensperger; Christopher Sie; Lilian Aly; Gildas Lepennetier; Thomas Engleitner; Garima Garg; Andreas Muschaweckh; Meike Mitsdörffer; Uwe Koedel; Bastian Höchst; Percy Knolle; Matthias Gunzer; Bernhard Hemmer; Roland Rad; Doron Merkler; Thomas Korn
Journal:  Nat Immunol       Date:  2018-10-29       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.